FAQ

SGB 1534

Known as: SGB-1534 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-1993
02419851993

Related topics

Related topics

1 relation

Broader (1)

Quinazolines

Related mentions per year

Related mentions per year

1945-2018
19401960198020002020
SGB 1534
Quinazolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Effects of a novel alpha 1-adrenoceptor antagonist, SGB-1534, on adrenergically induced renal vasoconstriction in dogs.
The alpha 1-adrenoceptor antagonistic effect of SGB-1534, a novel phenylpiperazine derivative, was examined in the renal vascular… (More)
Is this relevant?
1989
1989
Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay…
The comparative effects of antihypertensive agents, quinazoline or quinazolinedione residues (prazosin, bunazosin, terazosin, SGB… (More)
Is this relevant?
1989
1989
Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
In conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs, alpha-adrenoceptor antagonistic and… (More)
Is this relevant?
1988
1988
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
Effects of prazosin, dobutamine, isoproterenol and SGB-1534, a new alpha-blockade, on congestive heart failure (CHF) in dogs were… (More)
Is this relevant?
1988
1988
Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
Experiments in vitro and in vivo were undertaken to examine possible involvement of a central effect in the hypotensive mechanism… (More)
Is this relevant?
1988
1988
Effects of SGB-1534, a new synthesized phenylpiperazine derivative, on blood pressure and heart rate in stroke-prone spontaneously hypertensive rats.
The present study was undertaken to elucidate the effects of a new synthesized phenylpiperazine derivative SGB-1534 on mean… (More)
Is this relevant?
1986
1986
Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
The present study was designed to examine the antiplatelet activity of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2… (More)
Is this relevant?
1986
1986
Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
SGB-1534 inhibited the contractile response to norepinephrine (NE), methoxamine (MO) and electrical transmural stimulation in the… (More)
Is this relevant?
1985
1985
Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
The antihypertensive activities of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4 (1H,3H)-quinazolinedione… (More)
Is this relevant?
1985
1985
Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
The cardiovascular effects of SGB-1534 (3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]-2,4(1H,3H)-quinazolinedione monohydrochloride… (More)
Is this relevant?